Fresenius SE EPS - Earnings per Share 2016-2024 | FSNUY

Fresenius SE earnings per share (EPS) for the twelve months ending September 30, 2024 was $-0.04, a 87.97% decline year-over-year.

  • Fresenius SE EPS for the quarter ending September 30, 2024 was $0.16, a 19.55% increase year-over-year.
  • Fresenius SE 2023 annual EPS was $-0.28, a 0% decline from 2023.
  • Fresenius SE 2023 annual EPS was $-0.28, a 144.17% decline from 2022.
  • Fresenius SE 2022 annual EPS was $0.64, a 0% decline from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Fresenius SE EPS - Earnings per Share 2016-2024 | FSNUY

  • Fresenius SE EPS for the quarter ending September 30, 2024 was $0.16, a 19.55% increase year-over-year.
  • Fresenius SE 2023 annual EPS was $-0.28, a 0% decline from 2023.
  • Fresenius SE 2023 annual EPS was $-0.28, a 144.17% decline from 2022.
  • Fresenius SE 2022 annual EPS was $0.64, a 0% decline from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Quest Diagnostics (DGX)$19.2B
DaVita (DVA)$12.4B
Encompass Health (EHC)$10.2B
Chemed (CHE)$8.4B
Elanco Animal Health (ELAN)$5.6B
Option Care Health (OPCH)$5.5B
RadNet (RDNT)$4.8B
LifeStance Health (LFST)$3.1B
Amedisys (AMED)$3B
Astrana Health (ASTH)$2.2B
Addus HomeCare (ADUS)$2.1B
U.S Physical Therapy (USPH)$1.3B
Aveanna Healthcare Holdings (AVAH)$968M
Pennant (PNTG)$927M
Atai Life Sciences (ATAI)$351M
Bioqual (BIOQ)$54M
Daxor (DXR)$35M
Ontrak (OTRK)$7M
MEDIROM Healthcare Technologies (MRM)$4M
IMAC Holdings (BACK)$1M
Psychemedics (PMD)$0M